RxDoctor Payments Data

Ashley Shelton, APRN

Family · Jonesboro, ARNPI 1194385989

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (47.9%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. Medtronic accounts for 86.9% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2022 at $9,096 and has fallen 98.7% since, to $122 in 2025. Among family clinicians in AR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$10,452in general payments, 2019–2025

Across 46 payments — averaging $227.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$9K
  • Biotissue Holdings Inc.$955
  • Edwards Lifesciences$284
  • Nevro Corp.$116
  • Idorsia Pharmaceuticals US Inc$18

What the payments were for

  • Speaking & faculty fees$4,59044%
  • Travel & lodging$5,01148%
  • Food & beverage$8518%

General payments by program year

21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,452 in reported general payments places this provider in the 95th percentile of 2,103 family providers in Arkansas.

See all family providers in Arkansas

Medicare billing

Part B allowed, 2024
$14,406
Medicare patients
41
Services billed
181

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Naloxone Hcl18$1,067
Tizanidine Hcl58$413
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen57$389
Gabapentin19$291

Paid to pharmacies, not to this prescriber.

Other family in Jonesboro

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →